These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 1664113
21. Inhibitory effect of cyclosporin A on eosinophil infiltration in the guinea-pig lung induced by antigen, platelet-activating factor and leukotriene B4. Lagente V, Carré C, Kyriacopoulos F, Boichot E, Mencia-Huerta JM, Braquet P. Eur Respir J; 1994 May; 7(5):921-6. PubMed ID: 8050549 [Abstract] [Full Text] [Related]
22. Effect of BRL-35135 on LTB4-induced guinea pig eosinophil chemotaxis. Sugasawa T, Morooka S. Agents Actions; 1992 Nov; 37(3-4):232-7. PubMed ID: 1363505 [Abstract] [Full Text] [Related]
23. The effect of eosinophil chemotactic factors on in vitro eosinopoiesis in the guinea pig. Czarnetzki BM, Pawelzik B. Blut; 1983 Nov; 47(5):287-96. PubMed ID: 6313099 [Abstract] [Full Text] [Related]
25. Specific binding of leukotriene B4 to guinea pig lung membranes. Saad M, Wong K. Biochem Biophys Res Commun; 1987 Feb 27; 143(1):364-71. PubMed ID: 3030320 [Abstract] [Full Text] [Related]
26. Sulochrin inhibits eosinophil activation and chemotaxis. Ohashi H, Motegi Y, Kita H, Gleich GJ, Miura T, Ishikawa M, Kawai H, Fukamachi H. Inflamm Res; 1998 Oct 27; 47(10):409-15. PubMed ID: 9831326 [Abstract] [Full Text] [Related]
27. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions. Kishikawa K, Tateishi N, Maruyama T, Seo R, Toda M, Miyamoto T. Prostaglandins; 1992 Oct 27; 44(4):261-75. PubMed ID: 1332129 [Abstract] [Full Text] [Related]
28. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. Showell HJ, Pettipher ER, Cheng JB, Breslow R, Conklyn MJ, Farrell CA, Hingorani GP, Salter ED, Hackman BC, Wimberly DJ. J Pharmacol Exp Ther; 1995 Apr 27; 273(1):176-84. PubMed ID: 7714764 [Abstract] [Full Text] [Related]
29. [3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site. Cheng JB, Cheng EI, Kohi F, Townley RG. J Pharmacol Exp Ther; 1986 Jan 27; 236(1):126-32. PubMed ID: 3001280 [Abstract] [Full Text] [Related]
30. In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. Czarnetzki BM, Mertensmeier R. Prostaglandins; 1985 Jul 27; 30(1):5-11. PubMed ID: 2996056 [Abstract] [Full Text] [Related]
31. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid. Sehmi R, Cromwell O, Taylor GW, Kay AB. J Immunol; 1991 Oct 01; 147(7):2276-83. PubMed ID: 1655889 [Abstract] [Full Text] [Related]
32. Antihistaminic and antiallergic properties of dextro-mequitamium iodide in upper and lower guinea pig airways: comparison with azelastine. Evangelista S, Boni P, Castellucci A, Perretti F, Pretolani M, Joseph D, Renzetti AR, Subissi A, Manzini S. Gen Pharmacol; 1998 Apr 01; 30(4):513-9. PubMed ID: 9522168 [Abstract] [Full Text] [Related]
33. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543. Showell HJ, Conklyn MJ, Alpert R, Hingorani GP, Wright KF, Smith MA, Stam E, Salter ED, Scampoli DN, Meltzer S, Reiter LA, Koch K, Piscopio AD, Cortina SR, Lopez-Anaya A, Pettipher ER, Milici AJ, Griffiths RJ. J Pharmacol Exp Ther; 1998 Jun 01; 285(3):946-54. PubMed ID: 9618393 [Abstract] [Full Text] [Related]
34. Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178. Ohmi N, Tani C, Yamada K, Fukui M. Inflammation; 1994 Apr 01; 18(2):129-40. PubMed ID: 8070898 [Abstract] [Full Text] [Related]
35. Leukotriene B4 binding sites in guinea-pig alveolar macrophages. de Brum-Fernandes AJ, Guillemette G, Sirois P. Prostaglandins; 1990 Nov 01; 40(5):515-27. PubMed ID: 2175041 [Abstract] [Full Text] [Related]
36. Leukotriene B4 activates the NADPH oxidase in eosinophils by a pertussis toxin-sensitive mechanism that is largely independent of arachidonic acid mobilization. Lindsay MA, Perkins RS, Barnes PJ, Giembycz MA. J Immunol; 1998 May 01; 160(9):4526-34. PubMed ID: 9574559 [Abstract] [Full Text] [Related]
37. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs. Asanuma F, Kuwabara K, Arimura A, Furue Y, Fleisch JH, Hori Y. Inflamm Res; 2001 Mar 01; 50(3):136-41. PubMed ID: 11339501 [Abstract] [Full Text] [Related]
38. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro. Czarnetzki BM, Rosenbach T. Prostaglandins; 1986 May 01; 31(5):851-8. PubMed ID: 3014612 [Abstract] [Full Text] [Related]
39. Effect of chemotactic agents on rat and guinea pig eosinophil cytotoxicity in vitro. Musgrove NR, Cook RM. Int Arch Allergy Appl Immunol; 1988 May 01; 86(3):319-24. PubMed ID: 2841243 [Abstract] [Full Text] [Related]
40. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. J Clin Invest; 1986 Dec 01; 78(6):1701-6. PubMed ID: 3023451 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]